AMFI Registered MFD · ARN-130934 · Mutual fund investments are subject to market risks. CA Amit Kumar Jain · +91 93522 44475 Poornima Jain · +91 92525 44475 support@plenitude.co.in हिंदी

TAKE LIMITED share price

TAKE LIMITED, together with its subsidiaries, provides domain-intensive services in life sciences and supply chain industries in India. The company offers intelligent platforms across life sciences, clinical research, biotechnology, and preventive healthcare. It also provides collaboration platform services, including subscription based software, implementation and configuration, maintenance and support, and other professional services. The company was formerly known as TAKE Solutions Limited and change its name to TAKE LIMITED in June 2026. TAKE LIMITED was incorporated in 2000 and is based in Chennai, India.Read more
HealthcareHealth Information ServicesNSE: TAKEISIN INE142I01023
16 Oct 2026, 3:29 PM IST₹12.58▲ 0.55 (4.57%)
  • Market Cap₹ 184 Cr.
  • Current Price₹ 12.58
  • High / Low₹ 50 / 11
  • Stock P/E32.3
  • Book Value₹ 2
  • Dividend Yield0.00 %
  • ROCE15.4 %
  • ROE42.10 %
  • Face Value₹ 1.0
More figures (10)
  • EPS (TTM)₹ 0.39
  • Price / Book6.10
  • OPM-3.5 %
  • Debt / Equity0.00
  • Sales growth (5Y)-41.2 %
  • Profit growth (5Y)—
  • Promoter holding62.2 %
  • EV / EBITDA-109.9
  • Beta0.38
  • All-time high₹ 308

Price chart

Returns1M3M6MYTD1Y3Y CAGR5Y CAGR
TAKE-28.81%-37.26%-73.90%-68.50%-35.75%-15.83%-24.46%
Nifty 50-0.31%-3.85%-4.34%-11.42%-9.53%+5.46%+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

  • TAKE LIMITED is in the Health Information Services industry (Healthcare), with a market value of ₹184 crore.
  • It trades at 32.3 times its last 12 months' earnings and 6.1 times book value.
  • Revenue grew -41.2% a year over the last 5 years.
  • Return on equity was 42.1% and return on capital employed 15.4% in the latest year.
  • Debt was 0.00 times shareholders' equity.
  • The share price is 74.9% below its 52-week high and down 35.8% over one year.
  • Promoters and insiders hold about 62.2%; institutions about 0.0%.

Pros

  • Strong return on equity: 148.4% on average over the last 3 years.
  • Company is almost debt-free (debt is 0.00 times equity).

Cons

  • Sales growth has been slow: -41.2% a year over the last 5 years.
  • Other income makes up 132% of profit before tax.
  • Trades at 32.3 times earnings, above its 3-year median of 13.4.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About TAKE LIMITED

TAKE LIMITED, together with its subsidiaries, provides domain-intensive services in life sciences and supply chain industries in India. The company offers intelligent platforms across life sciences, clinical research, biotechnology, and preventive healthcare. It also provides collaboration platform services, including subscription based software, implementation and configuration, maintenance and support, and other professional services. The company was formerly known as TAKE Solutions Limited and change its name to TAKE LIMITED in June 2026. TAKE LIMITED was incorporated in 2000 and is based in Chennai, India.

Employees
5
Head office
Chennai

Peer comparison

HealthcareHealth Information Services

S.No.CompanyCMP ₹P/EMar Cap ₹ CrDiv Yld %NP Qtr ₹ CrQtr Profit Var %Sales Qtr ₹ CrQtr Sales Var %ROCE %
1.TAKE12.5832.31840.001—30—15.4
2.Inventurus Knowledge Solutions1,731.4038.729,0460.0019431.0889423.4429.6
3.Sagility45.3021.421,2060.4421745.941,96327.5912.5
4.Indegene598.3036.014,4090.38116-0.171,06339.7315.3
5.Fabtech Technologies130.3010.65790.454—7510.2611.8
Median: 5 Co.130.3032.314,4090.3811631.0889425.5115.3

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ CrJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
171817135430
1916162821311005531
Operating Profit-121-15-2-1-3-1-1-0-0-1-0
OPM %-7%10%7%-115%-2%-1%
0010920151
Interest211101100000
Depreciation2222000000000
Profit before tax-5-2-1-111-3-250-1-0141
-5-2-2-111-4-248-5-16141
EPS in Rs-0.36-0.11-0.15-7.56-0.26-0.113.26-0.33-0.060.430.070.290.07
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ CrMar 2017Mar 2018Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,5871,5872,213774655189665485
1,2811,2812,0448476482087975686
Operating Profit306306169-737-19-13-7-2-2
OPM %19%19%8%-9%1%-10%-21%-4%-2%
66261217821078
Interest212141372975200
Depreciation10410416711580178000
Profit before tax188188-13-439-85-45-118146
15%15%4%3%
160160-11-450-782-100-120371113
EPS in Rs12.1912.19-0.85-30.91-53.50-6.86-8.182.560.740.86
Dividend Payout %0%3%

Compounded Sales Growth

5 Years:
-41%
3 Years:
-34%

Compounded Profit Growth

TTM:
-68%

Stock Price CAGR

5 Years:
-24%
3 Years:
-16%
1 Year:
-36%

Return on Equity

4 Years:
88%
Last Year:
42%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ CrMar 2023Mar 2024Mar 2025Mar 2026
Equity Capital15151515
Reserves94-23616
4637
6960165
Total Liabilities224883636
54280
CWIP35
136603636
Total Assets224883636

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ CrMar 2023Mar 2024Mar 2025Mar 2026
209-16-4
-2-7222
-36-12-3-1
Net Cash Flow-18-103-3
Free Cash Flow-121-16-4

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

RatioMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROE—-92.3%-239.9%643.0%42.1%
ROCE—-30.9%5,712.5%13.2%15.4%
Operating margin—3.1%-181.0%—-3.5%
Net margin—-53.0%-3,320.9%—20.0%
Debt / equity—0.43-4.180.000.00
Current ratio—0.890.401.484.54
Debtor days—58714—1
Inventory days—392—0
Days payable—1042,020—9
Cash conversion cycle—-43-1,214—-8
Working capital days—-21-5,459—125

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

  • FIIs 0.21%
  • Public 99.79%
%Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters53.41%53.41%53.41%53.41%53.41%53.41%53.41%53.34%5.19%
0.02%0.56%0.29%0.21%
DIIs0.01%
46.59%46.59%46.57%46.59%46.59%46.59%46.58%46.66%94.81%99.44%99.71%99.79%
No. of Shareholders81,18379,33681,93880,28878,03377,16375,98875,14174,41070,32464,69963,213

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Documents

Announcements

All announcements on NSE →

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date
1 Aug 2019
Latest quarter
30 Jun 2026
Financial year end
31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Latest news

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about TAKE LIMITED

What is the share price of TAKE LIMITED today?
TAKE LIMITED (TAKE) last traded at ₹12.58 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.
What is the market cap of TAKE LIMITED?
About ₹184 crore at the latest price.
What is the P/E ratio of TAKE LIMITED?
About 32.3 times its earnings over the last 12 months.
Is TAKE LIMITED a good investment?
We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.
How can I buy TAKE LIMITED shares?
You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.
Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).
Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

  • 100% free
  • No obligation
  • Reply within 2 hours
+91
Join 2,000+ investors who plan with Plenitude
Your details are private and never shared.
WhatsApp Book free call